News

Neurona Therapeutics Prepares for Key October Investor Engagements

Neurona Therapeutics Prepares for Key October Investor Engagements

Neurona Therapeutics Prepares for Key October Investor Engagements

Neurona Therapeutics, a pioneering clinical-stage biotherapeutics company dedicated to advancing regenerative cell therapies for nervous system disorders, is gearing up for an exciting month.

Upcoming Conferences

Cory R. Nicholas, Ph.D., the Co-Founder and Chief Executive Officer of Neurona, is set to engage with investors during notable conferences in October. These events offer valuable insights into the company's innovative approaches in neuroscience and regenerative medicine.

William Blair's Innovator Series

The first event, the 2024 William Blair's Innovator Series: Private Biotechnology Stars, will feature a fireside chat on Thursday, October 3. This virtual chat is an opportunity for potential investors to learn about Neurona's cutting-edge research and clinical advancements starting at 6:00 am PT / 8:00 am CT.

Leerink Partners Event

Following that, Neurona will participate in the Leerink Partners Biopharma Private Company Connect event. Scheduled for Tuesday, October 22, and Wednesday, October 23, these one-on-one investor meetings will allow for deeper discussions about the company's trajectory and growth potential, all conducted virtually.

Replay Availability

Investors who cannot attend the live fireside chat can access a replay through the News section of Neurona's website, where it will be available for seven days following the event. This accessibility ensures that even those unable to join live will not miss out on the critical updates and information shared by Neurona's leadership.

About Neurona Therapeutics

Neurona Therapeutics is at the forefront of developing allogeneic, off-the-shelf regenerative neural cell therapy products. These therapies hold the promise of long-term, targeted repair of the nervous system from a single administration. At the center of their clinical endeavors is the candidate NRTX-1001, which consists of GABAergic interneurons currently undergoing evaluation for safety and efficacy in two ongoing multicenter Phase 1/2 trials.

Clinical Trials Overview

This innovative candidate is being studied for drug-resistant unilateral mesial temporal lobe epilepsy and drug-resistant bilateral mesial temporal lobe epilepsy. Neurona also has plans for future indications including neocortical focal epilepsy. This is a significant stride towards addressing complex neurological conditions that have limited treatment options.

Funding and Support

The clinical trial for unilateral MTLE is further supported by an $8.0 million grant from the California Institute for Regenerative Medicine (CIRM). Notably, the FDA granted NRTX-1001 the Regenerative Medicine Advanced Therapy (RMAT) designation earlier in the year, a testament to the promising clinical data generated thus far.

Recent Developments

In an impressive funding round in February 2024, Neurona secured $120 million, co-led by influential investors, Viking Global Investors and Cormorant Asset Management. This infusion of capital is expected to propel the company’s mission of delivering advanced treatments aimed at repairing nervous system damage.

Investor Contact Information

For more details, interested parties can reach out to Laurence Watts at New Street Investor Relations. The investor contact email is available for those seeking further engagement regarding the company's trajectory and stock information.

Frequently Asked Questions

What is Neurona Therapeutics focused on?

Neurona Therapeutics specializes in regenerative cell therapies targeting nervous system disorders.

Who will be speaking at the conferences?

Cory R. Nicholas, Ph.D., the CEO, will represent Neurona at the upcoming conferences.

Where can I find replays of the investor events?

Replays will be available on the Neurona website's News section for seven days after the live events.

What is NRTX-1001?

NRTX-1001 is Neurona's lead product candidate, designed to treat drug-resistant mesial temporal lobe epilepsy.

How is Neurona funding its clinical trials?

The trials are supported by grants and recent funding, including an $8.0 million grant from CIRM.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 5

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading
Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
EZ Elephant's Ladder-Free Gutter Fix Debuts at Expo

Updated Category News Views 4

A New Leaf in Gutter Maintenance From the ground up, EZ Elephant is redefining how we tackle gutter maintenance. Picture it: never having to teeter on that wobbly ladder again just to unclog your gutters. This American-made solution, showcased at the Western Roofing Expo from September 27–29, 2026, is a game changer. Check out Booth #834 to see this marvel of innovation...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 4

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 4

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 11

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading
1.8M Moves in England: The Admin Maze Explained

Updated Category News Views 5

Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 4

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 8

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering High-Grade Gold Opportunities Amid Market Shifts

Updated Category News Views 75

Unveiling Potential in the Gold Market In a rapidly evolving gold market, the recent surge in gold prices above $4,300 per ounce has sparked significant interest in high-grade gold deposits. This market scenario has created a unique advantage for firms showcasing premium quality deposits, as major new gold discoveries have become increasingly rare. Strategic Players in...

Continue Reading
Coppernico Metals Enhances Option Agreement to Boost Exploration

Updated Category News Views 113

Coppernico Metals Strengthens Exploration Efforts in Peru VANCOUVER, British Columbia — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) is excited to announce the amendments made to its option agreements to bolster its exploration programs at the Sombrero Project. Through its subsidiary, Sombrero Minerales SAC, the company has taken significant steps to...

Continue Reading
Apple Inc. Shares See Pre-Market Weakness: Insights and Analysis

Updated Category News Views 72

Apple's Share Performance in Pre-Market Trading Apple Inc. (NASDAQ: AAPL) recently experienced a notable decline in its stock during pre-market trading. Shares fell 2.03%, bringing them down to $221.32 from Thursday's close of $225.91. This unexpected drop can be attributed to the company’s cautious sales growth outlook for the upcoming quarter. Understanding the Recent...

Continue Reading
Mongolian Mining Corporation Joins OTCQX for Greater Reach

Updated Category News Views 85

Mongolian Mining Corporation Joins OTCQX for Enhanced Market Presence In an exciting development, Mongolian Mining Corporation, a prominent player in the high-quality washed hard coking coal sector, has made a significant advancement by listing on the OTCQX Best Market. This upgrade reflects the company's commitment to providing robust trading opportunities for U.S....

Continue Reading
ThreeD Capital Inc. Expands Stake in AI/ML Innovations Inc.

Updated Category News Views 281

ThreeD Capital Inc. Expands Stake in AI/ML Innovations Inc. ThreeD Capital Inc. (“ThreeD”) is a well-known Canadian venture capital firm that has recently strengthened its investment portfolio through a strategic acquisition. Through a private placement, ThreeD and its key associate Sheldon Inwentash have successfully acquired a substantial number of common shares of...

Continue Reading